Asthma Therapeutics Market to Grow with a CAGR of 3.25% through 2029

Rising prevalence of asthma and increasing healthcare expenditure are factors driving the Global Asthma Therapeutics Market in the forecast period, 2025-2029. 

According to TechSci Research report, “Asthma Therapeutics Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029F”, the Global Asthma Therapeutics Market stood at USD 23.52 Billion in 2023 and is anticipated to grow with a CAGR of 3.25% through 2029. Asthma, a chronic respiratory condition characterized by inflammation and airway constriction, presents a substantial public health challenge worldwide, affecting millions of individuals and straining healthcare systems. Nonetheless, progress in medical research and healthcare technology has led to the development of more targeted and efficacious asthma treatments. These advancements have propelled the expansion of the global asthma therapeutics market as patients seek improved symptom management and enhanced quality of life.

In recent years, biologics, particularly monoclonal antibodies, have emerged as transformative therapies in asthma management. By precisely targeting underlying inflammation and immune pathways implicated in asthma, biologics offer more effective symptom control and reduced asthma attack frequency. Their introduction has revolutionized asthma treatment, providing patients with novel therapeutic options and better outcomes.

Personalized medicine is gaining traction in asthma management, aiming to tailor treatment strategies to individual patients based on their genetic profile, environmental factors, and specific triggers. By addressing individual risk factors and treatment preferences, personalized medicine offers a more tailored and precise approach to asthma care. As it becomes more accessible and affordable, personalized medicine is expected to drive growth in the global asthma therapeutics market significantly. Increased healthcare spending worldwide has also contributed to market growth, with rising disposable incomes and heightened health consciousness prompting greater investment in healthcare services, pharmaceuticals, and research. This increased investment has facilitated broader access to advanced treatment modalities and a wider array of medications for asthma patients, stimulating market expansion.

Pharmaceutical companies, academic institutions, and research organizations are actively investing in asthma-related research and development to discover novel therapeutic targets, develop new drug formulations, and enhance existing treatments. These efforts are expected to yield innovative solutions and broaden the market's product offerings, consequently driving growth. Government support and public health initiatives aimed at enhancing asthma management and control further propel market expansion. Many governments worldwide have implemented awareness campaigns, allocated funds for research, and promoted best practices in asthma care. By ensuring timely and effective treatment for asthma patients, government support significantly contributes to market growth and overall patient well-being.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Asthma Therapeutics Market”

The Global Asthma Therapeutics Market is segmented into drug class, product, route of administration, regional distribution and company.

Based on drug class, anti-inflammatory emerged as the dominating segment in the Global Asthma Therapeutics Market during the forecast period. Asthma is primarily defined by inflammation of the airways, resulting in symptoms like wheezing, breathlessness, and chest tightness. Corticosteroids, notably inhaled ones, are potent anti-inflammatory drugs that effectively mitigate this inflammation, easing symptoms and averting asthma flare-ups. Recognized as the initial treatment choice for managing asthma, inhaled corticosteroids (ICS) are advised for maintaining long-term control and preventing symptom flare-ups. Consequently, healthcare providers frequently prescribe these medications to asthma patients across different age groups and severity levels.

Based on region, the Asia Pacific region is witnessing rapid growth in the global asthma therapeutics market. This expansion can be attributed to various factors, notably the increasing accessibility of healthcare services and the widespread availability of comprehensive health insurance coverage. In numerous countries across the Asia Pacific region, individuals benefit from inclusive health insurance schemes that encompass a broad spectrum of treatments, including medications for asthma. This ensures that patients possess the financial resources necessary to obtain and adhere to their prescribed therapies, thereby fostering market growth. Heightened awareness regarding asthma management and treatment options, alongside initiatives aimed at enhancing healthcare infrastructure, are further propelling market expansion in the region. As healthcare systems continue to advance and healthcare accessibility improves, there is anticipated to be a significant uptick in demand for asthma therapeutics, particularly inhaled medications, across the Asia Pacific region, thus contributing to the overall growth of the global asthma therapeutics market.

Major companies operating in Global Asthma Therapeutics Market are:

• Teva Pharmaceutical Industries Ltd.
• GSK plc.
• Merck & Co., Inc.
• F. Hoffmann-La Roche Ltd. 
• AstraZeneca plc. 
• Boehringer Ingelheim International GmbH
• Sanofi S.A.
• Koninklijke Philips N.V.
• Becton, Dickinson and Company
• Sunovion Pharmaceuticals, Inc.

Download Free Sample Report

Customers can also request 10% free customization on this report

“The global asthma therapeutics market is expanding significantly due to advances in medical research and the increasing prevalence of asthma worldwide. Commonly prescribed medications like inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists are crucial for managing symptoms and preventing asthma attacks. Innovative treatments such as biologics, including monoclonal antibodies, offer targeted therapy for severe cases. Personalized medicine approaches tailor treatment plans to individual patient profiles. As healthcare infrastructure evolves and awareness of asthma management grows, the demand for asthma therapeutics is expected to rise, further driving global market expansion”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Asthma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Anti-inflammatory, Combination Therapy, Bronchodilators), By Product (Inhalers (Dry powder inhalers, Metered dose inhalers, Soft mist inhalers), Nebulizers), By Route of Administration (Oral, Inhaled, Others), By Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global Asthma Therapeutics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Asthma Therapeutics Market.

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]               

Website: www.techsciresearch.com